Dactinomycin
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Dactinomycin is a prescription injectable medication used in chemotherapy to treat certain cancers by inhibiting nucleic acid and protein synthesis. It comes as a lyophilized powder for intravenous injection, with each vial containing 0.5 mg, manufactured by XGen Pharmaceuticals DJB, Inc. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Dactinomycin
Access the FDA dataset for Dactinomycin β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025